annual cost of goods sold:
$623.49M+$46.43M(+8.05%)Summary
- As of today (September 13, 2025), BMRN annual cost of goods sold is $623.49 million, with the most recent change of +$46.43 million (+8.05%) on December 31, 2024.
- During the last 3 years, BMRN annual cost of goods sold has risen by +$91.04 million (+17.10%).
- BMRN annual cost of goods sold is now at all-time high.
Performance
BMRN Cost of goods sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cost of goods sold:
$154.94M+$3.38M(+2.23%)Summary
- As of today (September 13, 2025), BMRN quarterly cost of goods sold is $154.94 million, with the most recent change of +$3.38 million (+2.23%) on June 30, 2025.
- Over the past year, BMRN quarterly cost of goods sold has increased by +$10.18 million (+7.03%).
- BMRN quarterly cost of goods sold is now -25.15% below its all-time high of $206.99 million, reached on September 30, 2020.
Performance
BMRN quarterly cost of goods sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM cost of goods sold:
$645.75M+$10.18M(+1.60%)Summary
- As of today (September 13, 2025), BMRN TTM cost of goods sold is $645.75 million, with the most recent change of +$10.18 million (+1.60%) on June 30, 2025.
- Over the past year, BMRN TTM cost of goods sold has increased by +$70.37 million (+12.23%).
- BMRN TTM cost of goods sold is now at all-time high.
Performance
BMRN TTM cost of goods sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cost of goods sold Formula
COGS = Beginning Inventory + Purchases − Ending Inventory
BMRN Cost of goods sold Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +8.1% | +7.0% | +12.2% |
3 y3 years | +17.1% | +11.7% | +22.9% |
5 y5 years | +51.0% | +36.6% | +38.6% |
BMRN Cost of goods sold Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +17.1% | -19.9% | +17.2% | at high | +22.9% |
5 y | 5-year | at high | +51.0% | -25.1% | +36.6% | at high | +38.6% |
alltime | all time | at high | >+9999.0% | -25.1% | >+9999.0% | at high | >+9999.0% |
BMRN Cost of goods sold History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $154.94M(+2.2%) | $645.75M(+1.6%) |
Mar 2025 | - | $151.56M(+4.0%) | $635.57M(+1.9%) |
Dec 2024 | $623.49M(+8.0%) | $145.79M(-24.6%) | $623.49M(-0.8%) |
Sep 2024 | - | $193.47M(+33.6%) | $628.42M(+9.2%) |
Jun 2024 | - | $144.76M(+3.8%) | $575.38M(+0.2%) |
Mar 2024 | - | $139.48M(-7.5%) | $574.30M(-0.5%) |
Dec 2023 | $577.07M(+5.6%) | $150.71M(+7.3%) | $577.07M(+1.4%) |
Sep 2023 | - | $140.43M(-2.3%) | $569.30M(+1.5%) |
Jun 2023 | - | $143.68M(+1.0%) | $561.07M(+0.9%) |
Mar 2023 | - | $142.25M(-0.5%) | $556.11M(+1.8%) |
Dec 2022 | $546.46M(+2.6%) | $142.95M(+8.1%) | $546.43M(+1.4%) |
Sep 2022 | - | $132.19M(-4.7%) | $538.81M(+2.5%) |
Jun 2022 | - | $138.73M(+4.6%) | $525.59M(-0.7%) |
Mar 2022 | - | $132.56M(-2.0%) | $529.42M(-0.6%) |
Dec 2021 | $532.45M(-9.2%) | $135.34M(+13.8%) | $532.42M(-1.2%) |
Sep 2021 | - | $118.96M(-16.6%) | $538.83M(-14.0%) |
Jun 2021 | - | $142.56M(+5.2%) | $626.86M(+4.9%) |
Mar 2021 | - | $135.57M(-4.4%) | $597.75M(+1.4%) |
Dec 2020 | $586.47M(+42.0%) | $141.74M(-31.5%) | $589.24M(+5.3%) |
Sep 2020 | - | $206.99M(+82.4%) | $559.70M(+20.1%) |
Jun 2020 | - | $113.46M(-10.7%) | $465.93M(+5.1%) |
Mar 2020 | - | $127.06M(+13.2%) | $443.29M(+7.4%) |
Dec 2019 | $412.97M(+19.5%) | $112.20M(-0.9%) | $412.92M(+7.7%) |
Sep 2019 | - | $113.21M(+24.7%) | $383.33M(+7.5%) |
Jun 2019 | - | $90.82M(-6.1%) | $356.62M(+1.2%) |
Mar 2019 | - | $96.68M(+17.0%) | $352.31M(+2.0%) |
Dec 2018 | $345.56M(+24.3%) | $82.62M(-4.5%) | $345.56M(-2.0%) |
Sep 2018 | - | $86.49M(-0.0%) | $352.44M(+5.8%) |
Jun 2018 | - | $86.52M(-3.8%) | $333.03M(+7.3%) |
Mar 2018 | - | $89.93M(+0.5%) | $310.41M(+11.7%) |
Dec 2017 | $277.99M(+15.9%) | $89.50M(+33.4%) | $277.99M(+6.9%) |
Sep 2017 | - | $67.08M(+5.0%) | $260.14M(+3.5%) |
Jun 2017 | - | $63.91M(+11.1%) | $251.40M(+5.1%) |
Mar 2017 | - | $57.51M(-19.7%) | $239.11M(+3.0%) |
Dec 2016 | $239.82M(+47.3%) | $71.65M(+22.8%) | $232.22M(+9.8%) |
Sep 2016 | - | $58.34M(+13.0%) | $211.52M(+10.9%) |
Jun 2016 | - | $51.62M(+2.0%) | $190.70M(+5.8%) |
Mar 2016 | - | $50.62M(-0.6%) | $180.16M(+10.2%) |
Dec 2015 | $162.81M(+20.8%) | $50.94M(+35.8%) | $163.50M(+2.0%) |
Sep 2015 | - | $37.52M(-8.7%) | $160.33M(+4.2%) |
Jun 2015 | - | $41.08M(+21.0%) | $153.87M(+6.1%) |
Mar 2015 | - | $33.96M(-28.9%) | $144.97M(+7.7%) |
Dec 2014 | $134.73M(+36.2%) | $47.77M(+53.8%) | $134.62M(+11.4%) |
Sep 2014 | - | $31.05M(-3.5%) | $120.85M(-5.5%) |
Jun 2014 | - | $32.18M(+36.3%) | $127.89M(-0.4%) |
Mar 2014 | - | $23.62M(-30.6%) | $128.46M(-4.2%) |
Dec 2013 | $98.94M(+4.1%) | $34.01M(-10.7%) | $134.04M(-1.8%) |
Sep 2013 | - | $38.09M(+16.3%) | $136.57M(+10.2%) |
Jun 2013 | - | $32.74M(+12.1%) | $123.94M(+6.1%) |
Mar 2013 | - | $29.20M(-20.1%) | $116.81M(+9.1%) |
Dec 2012 | $95.03M | $36.53M(+43.5%) | $107.05M(+5.3%) |
Sep 2012 | - | $25.46M(-0.6%) | $101.66M(+2.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2012 | - | $25.62M(+31.8%) | $99.45M(+5.9%) |
Mar 2012 | - | $19.43M(-37.6%) | $93.89M(-1.8%) |
Dec 2011 | $119.15M(+55.4%) | $31.15M(+34.0%) | $95.56M(+12.3%) |
Sep 2011 | - | $23.25M(+15.9%) | $85.08M(+2.8%) |
Jun 2011 | - | $20.06M(-5.0%) | $82.77M(+5.2%) |
Mar 2011 | - | $21.11M(+2.1%) | $78.69M(+4.9%) |
Dec 2010 | $76.69M(+11.4%) | $20.67M(-1.3%) | $74.99M(+13.3%) |
Sep 2010 | - | $20.93M(+31.0%) | $66.19M(+9.8%) |
Jun 2010 | - | $15.98M(-8.2%) | $60.28M(-8.6%) |
Mar 2010 | - | $17.41M(+46.7%) | $65.92M(+3.1%) |
Dec 2009 | $68.82M(+21.0%) | $11.87M(-21.0%) | $63.96M(-1.4%) |
Sep 2009 | - | $15.02M(-30.6%) | $64.85M(-0.2%) |
Jun 2009 | - | $21.62M(+39.9%) | $64.99M(+20.2%) |
Mar 2009 | - | $15.46M(+21.1%) | $54.05M(-5.0%) |
Dec 2008 | $56.88M(+150.2%) | $12.76M(-15.8%) | $56.88M(+12.8%) |
Sep 2008 | - | $15.16M(+41.8%) | $50.44M(+23.5%) |
Jun 2008 | - | $10.69M(-41.5%) | $40.84M(+14.1%) |
Mar 2008 | - | $18.28M(+189.4%) | $35.80M(+57.5%) |
Dec 2007 | $22.73M(+9.8%) | $6.32M(+13.8%) | $22.73M(+0.6%) |
Sep 2007 | - | $5.55M(-1.7%) | $22.59M(-6.6%) |
Jun 2007 | - | $5.65M(+8.4%) | $24.17M(+11.3%) |
Mar 2007 | - | $5.21M(-15.7%) | $21.72M(+4.6%) |
Dec 2006 | $20.70M(+62.9%) | $6.18M(-13.5%) | $20.77M(+18.3%) |
Sep 2006 | - | $7.14M(+123.5%) | $17.55M(+32.7%) |
Jun 2006 | - | $3.19M(-25.0%) | $13.22M(+4.7%) |
Mar 2006 | - | $4.26M(+43.9%) | $12.63M(+12.6%) |
Dec 2005 | $12.70M(-26.3%) | $2.96M(+5.2%) | $11.21M(-7.8%) |
Sep 2005 | - | $2.81M(+8.3%) | $12.15M(-22.0%) |
Jun 2005 | - | $2.60M(-8.6%) | $15.58M(-8.3%) |
Mar 2005 | - | $2.84M(-27.3%) | $17.00M(+20.1%) |
Dec 2004 | $17.23M(+82.5%) | $3.90M(-37.5%) | $14.16M(+38.1%) |
Sep 2004 | - | $6.24M(+55.5%) | $10.26M(+47.7%) |
Jun 2004 | - | $4.01M(+36.9%) | $6.95M(+29.2%) |
Dec 2003 | $9.44M(+11.0%) | - | - |
Sep 2003 | - | $2.93M(+19.9%) | $5.38M(-36.8%) |
Dec 2002 | $8.50M(+37.8%) | $2.44M(+9.2%) | $8.50M(+40.4%) |
Sep 2002 | - | $2.24M(+13.7%) | $6.06M(-0.6%) |
Jun 2002 | - | $1.97M(+6.3%) | $6.10M(-10.6%) |
Mar 2002 | - | $1.85M(-18.6%) | $6.82M(-13.7%) |
Dec 2001 | $6.17M(-7.4%) | - | - |
Sep 2001 | - | $2.27M(-15.4%) | $7.90M(+7.1%) |
Jun 2001 | - | $2.69M(+131.5%) | $7.38M(+19.4%) |
Mar 2001 | - | $1.16M(-34.5%) | $6.18M(-7.3%) |
Dec 2000 | $6.67M(+17.3%) | $1.77M(+1.2%) | $6.67M(-15.5%) |
Sep 2000 | - | $1.75M(+17.7%) | $7.89M(+4.3%) |
Jun 2000 | - | $1.49M(-9.5%) | $7.56M(+6.9%) |
Mar 2000 | - | $1.65M(-45.0%) | $7.08M(+13.7%) |
Dec 1999 | $5.68M(+727.0%) | $3.00M(+109.3%) | $6.22M(+92.8%) |
Sep 1999 | - | $1.43M(+42.7%) | $3.23M(+79.6%) |
Jun 1999 | - | $1.00M(+26.3%) | $1.80M(+126.3%) |
Mar 1999 | - | $794.10K | $794.10K |
Dec 1998 | $686.90K(>+9900.0%) | - | - |
Dec 1997 | $4800.00 | - | - |
FAQ
- What is BioMarin Pharmaceutical Inc. annual cost of goods sold?
- What is the all time high annual cost of goods sold for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. annual cost of goods sold year-on-year change?
- What is BioMarin Pharmaceutical Inc. quarterly cost of goods sold?
- What is the all time high quarterly cost of goods sold for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. quarterly cost of goods sold year-on-year change?
- What is BioMarin Pharmaceutical Inc. TTM cost of goods sold?
- What is the all time high TTM cost of goods sold for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. TTM cost of goods sold year-on-year change?
What is BioMarin Pharmaceutical Inc. annual cost of goods sold?
The current annual cost of goods sold of BMRN is $623.49M
What is the all time high annual cost of goods sold for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high annual cost of goods sold is $623.49M
What is BioMarin Pharmaceutical Inc. annual cost of goods sold year-on-year change?
Over the past year, BMRN annual cost of goods sold has changed by +$46.43M (+8.05%)
What is BioMarin Pharmaceutical Inc. quarterly cost of goods sold?
The current quarterly cost of goods sold of BMRN is $154.94M
What is the all time high quarterly cost of goods sold for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high quarterly cost of goods sold is $206.99M
What is BioMarin Pharmaceutical Inc. quarterly cost of goods sold year-on-year change?
Over the past year, BMRN quarterly cost of goods sold has changed by +$10.18M (+7.03%)
What is BioMarin Pharmaceutical Inc. TTM cost of goods sold?
The current TTM cost of goods sold of BMRN is $645.75M
What is the all time high TTM cost of goods sold for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high TTM cost of goods sold is $645.75M
What is BioMarin Pharmaceutical Inc. TTM cost of goods sold year-on-year change?
Over the past year, BMRN TTM cost of goods sold has changed by +$70.37M (+12.23%)